May/June 2026
May/June 2026 | Features
Pearls and Pitfalls of Treating GA and Wet AMD
Concurrent therapy can pose clinical challenges. Here’s how you can manage these patients and maximize outcomes.
Sean D. Adrean, MD, FAAO, and Wesley Han, BS
May/June 2026 | Features
Novel MOAs in Wet AMD
The pipeline is full of therapies that hold promise for extending treatment efficacy.
Lejla Vajzovic, MD, FASRS; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi
Popular Articles
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Supplement | Digital Supplement
From Vascular Curiosity to Neurodegenerative Disease: A Consensus Statement for the Diagnosis and Management of Macular Telangiectasia Type 2
Lejla Vajzovic, MD, FASRS; Sophie Bakri, MD; W. Lloyd Clark, MD; Diana Do, MD; Dean Eliott, MD; Roger Goldberg, MD; and Dante Pieramici, MD
April 2026 | Features
The Value of OCTA in Retinal Vascular Disease
Measuring retinal blood flow is easier than ever before, with new tools under investigation to further improve our ability to assess changes in the retinal vasculature.
Sarah Aman, MD; Viet-Hoan Le, PhD; Ruikang K. Wang, PhD; and Amir H. Kashani, MD, PhD
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD